L3VLUP
ProSign in

LIVN · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

LIVNJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • LIVN
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterLIVNJNJ
Q3 20207 holders, $358m30 holders, $26.2bn
Q4 20205 holders, $373m32 holders, $26.6bn
Q1 20213 holders, $390m31 holders, $25.3bn
Q2 20216 holders, $550m37 holders, $25.6bn
Q3 20219 holders, $674m40 holders, $24.1bn
Q4 20218 holders, $753m33 holders, $25.2bn
Q1 20226 holders, $662m35 holders, $28.2bn
Q2 20227 holders, $563m33 holders, $26.9bn
Q3 20225 holders, $330m36 holders, $25.4bn
Q4 20226 holders, $222m35 holders, $27.6bn
Q1 20237 holders, $99m42 holders, $24.5bn
Q2 20237 holders, $204m38 holders, $25.0bn
Q3 20236 holders, $293m37 holders, $18.9bn
Q4 20237 holders, $300m31 holders, $19.0bn
Q1 20246 holders, $290m32 holders, $19.7bn
Q2 20247 holders, $364m35 holders, $20.4bn
Q3 20249 holders, $465m28 holders, $22.3bn
Q4 202413 holders, $457m37 holders, $20.4bn
Q1 20259 holders, $332m32 holders, $20.5bn
Q2 20257 holders, $332m31 holders, $18.4bn
Q3 20256 holders, $390m32 holders, $23.7bn
Q4 20258 holders, $673m29 holders, $27.8bn
Q1 20267 holders, $491m34 holders, $35.6bn
Q2 20266 holders, $583m33 holders, $39.1bn
LIVN

Livanova PLC

Holders
9
Reported value
$465m
Buyers
7
Sellers
2

Breadth +5 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
28
Reported value
$22.3bn
Buyers
13
Sellers
16

Breadth -3 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2024

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only LIVN (5)

Greenlight Capital, Millennium Management LLC, Point72 Asset Management LP, Quantbot Technologies LP, Tudor Investment Corp

Only JNJ (24)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Markel Group Inc, MFS Investment Management, Neuberger Berman Group LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Walleye Capital LLC, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →